Serious Shortage In Vaccines Provided By Kitasato Daiichi Sankyo In Japan
This article was originally published in PharmAsia News
Executive Summary
Kitasato Daiichi Sankyo will not be able to complete the provision of 40 million influenza H5N1 vaccines as promised by the end of March, according to a recent report by Japan’s Ministry of Health, Labor and Welfare.